Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.
Journal: Science translational medicine
Published: January 21, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 04, 2025
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.
Journal: Nature medicine
Published: June 27, 2025
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.
Journal: Nature communications
Published: April 07, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma.
Journal: Future oncology (London, England)
Published: February 11, 2025
Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.
Journal: Scientific reports
Published: November 26, 2024
Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 04, 2024
Improving Collection and Analysis of Overall Survival Data.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 20, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Journal: Lancet (London, England)
Published: December 21, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 27, 2023
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study.
Journal: JACC. CardioOncology
Published: July 05, 2023
Last Updated: 09/26/2026